 |
 |

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In the Combined Pharmacotherapies and Behavioral Interventions (COMBINE) Study, Dr Anton and colleagues1 evaluated the effects of combining medications with behavioral interventions in treatment of alcohol dependence. While all 9 study groups showed marked reductions in drinking from baseline to end of study, treatment with acamprosate, naltrexone, or both when added to the background of medical management did not substantially improve percent days abstinent or time to first heavy drinking day (the 2 coprimary outcomes) compared with placebo and medical management, regardless of whether a combined behavioral intervention (CBI) was added.
In this multifactorial design, naltrexone statistically separated from nonnaltrexone groups on time to severe relapse but demonstrated a significant interaction with CBI for percent days abstinent. The direction of interaction indicatedthat the medication effect was weaker when CBI was added, an unexpected finding. Furthermore, the magnitude of additional benefits of naltrexone over placebo with medical management . . . [Full Text of this Article]
Jeffrey M. Jonas, MD
jeffrey.jonas@frx.com Forest Research Institute Jersey City, NJ
Sylvie Chabac, MD, MBA
Merck Santé Lyon, France
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Pharmacotherapy and Behavioral Intervention for Alcohol Dependence
Falk Kiefer and Karl Mann
JAMA. 2006;296(14):1727-1728.
EXTRACT
| FULL TEXT
Pharmacotherapy and Behavioral Intervention for Alcohol DependenceReply
Raymond F. Anton, William R. Miller, Stephanie S. OMalley, Allen Zweben, and James D. Hosking
JAMA. 2006;296(14):1728-1729.
EXTRACT
| FULL TEXT
Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Raymond F. Anton, Stephanie S. OMalley, Domenic A. Ciraulo, Ron A. Cisler, David Couper, Dennis M. Donovan, David R. Gastfriend, James D. Hosking, Bankole A. Johnson, Joseph S. LoCastro, Richard Longabaugh, Barbara J. Mason, Margaret E. Mattson, William R. Miller, Helen M. Pettinati, Carrie L. Randall, Robert Swift, Roger D. Weiss, Lauren D. Williams, Allen Zweben, and for the COMBINE Study Research Group
JAMA. 2006;295(17):2003-2017.
ABSTRACT
| FULL TEXT
|